---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-010231"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2022-04-18T23:59:59+00:00"
generated_at: "2026-06-26T06:46:36.477440+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CFO Marc Bregman resigns effective April 29, 2022; search underway

## Summary
- Marc Bregman notified his resignation as CFO, Treasurer, Secretary, and Principal Financial and Accounting Officer.
- His last day with the company will be April 29, 2022; he leaves to pursue another opportunity.
- The company has commenced a search for a replacement; no successor has been named.

## SEC filing metadata
- accession: 0001493152-22-010231
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2022-04-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315222010231/0001493152-22-010231-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315222010231/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-010231
- JSON: https://secwatch.observer/filing/0001493152-22-010231.json
- Plain text: https://secwatch.observer/filing/0001493152-22-010231.txt

## Key facts
- Executive change
  Marc Bregman resigned as Chief Financial Officer, Treasurer and Secretary at ELITE PHARMACEUTICALS INC /NV/.
  - Action: resigned
  - Role: Chief Financial Officer, Treasurer and Secretary
  source text: On April 14, 2022, Marc Bregman notified Elite Pharmaceuticals, Inc. (the “Company”) of his intent to leave the Company and resign from his position as Chief Financial Officer, Treasurer and Secretary to pursue another opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1053369/000149315222010231/0001493152-22-010231-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
